Literature DB >> 24350930

The challenges in moving from ageing to successful longevity.

Genovefa Kolovou, Nir Barzilai, Calogero Caruso, Ewa Sikora, Miriam Capri, Irene P Tzanetakou, Helen Bilianou, Peter Avery, Niki Katsiki, George Panotopoulos, Claudio Franceschi, Athanase Benetos, Dimitri P Mikhailidis1.   

Abstract

During the last decades survival has significantly improved and centenarians are becoming a fast-growing group of the population. Human life span is mainly dependent on environmental and genetic factors. Favourable modifications of lifestyle factors (e.g. physical activity, diet and not smoking) and healthcare (e.g. effective vascular disease prevention) have also increased human life span. Genetic factors contribute to the variation of human life span by around 25%, which is believed to be more profound after 85 years of age. It is likely that multiple factors influence life span and we need answers to questions such as: 1) What does it take to reach 100?, 2) Do centenarians have better health during their lifespan compared with contemporaries who died at a younger age?, 3) Do centenarians have protective modifications of body composition, fat distribution and energy expenditure, maintain high physical and cognitive function, and sustained engagement in social and productive activities?, 4) Do centenarians have genes which contribute to longevity?, 5) Do centenarians benefit from epigenetic phenomena?, 6) Is it possible to influence the transgenerational epigenetic inheritance (epigenetic memory) which leads to longevity?, 7) Is the influence of nutrigenomics important for longevity?, 8) Do centenarians benefit more from drug treatment, particularly in primary prevention?, and, 9) Are there any potential goals for drug research? Many definitions of successful ageing have been proposed, but at present there is no consensus definition. Such definitions may need to differentiate between "Longevity Syndrome" and "Exceptional Longevity".

Entities:  

Mesh:

Year:  2014        PMID: 24350930     DOI: 10.2174/1570161111666131219095114

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  6 in total

1.  Serum anti-inflammatory and inflammatory markers have no causal impact on telomere length: a Mendelian randomization study.

Authors:  Mohsen Mazidi; Niloofar Shekoohi; Niki Katsiki; Michal Rakowski; Dimitri P Mikhailidis; Maciej Banach
Journal:  Arch Med Sci       Date:  2021-04-21       Impact factor: 3.318

Review 2.  Possible role of ABO system in age-related diseases and longevity: a narrative review.

Authors:  Claudia Rizzo; Calogero Caruso; Sonya Vasto
Journal:  Immun Ageing       Date:  2014-11-01       Impact factor: 6.400

3.  Spatio-Temporal Variation of Longevity Clusters and the Influence of Social Development Level on Lifespan in a Chinese Longevous Area (1982-2010).

Authors:  Jian Qin; Guoqi Yu; Tianlong Xia; You Li; Xue Liang; Peng Wei; Bingshuang Long; Mingzhi Lei; Xiao Wei; Xianyan Tang; Zhiyong Zhang
Journal:  Int J Environ Res Public Health       Date:  2017-07-19       Impact factor: 3.390

Review 4.  Successful Aging and Chronic Osteoarthritis.

Authors:  Ray Marks
Journal:  Medicines (Basel)       Date:  2018-09-19

5.  Biomarkers and Gene Polymorphisms in Members of Long- and Short-lived Families: A Longevity Study.

Authors:  Vana Kolovou; Olga Diakoumakou; Athanasia K Papazafiropoulou; Niki Katsiki; Elisabeth Fragopoulou; Ioannis Vasiliadis; Dimitris Degiannis; Leonidas Duntas; Smaragdi Antonopoulou; Genovefa Kolovou
Journal:  Open Cardiovasc Med J       Date:  2018-07-31

6.  Nutrigerontology: a key for achieving successful ageing and longevity.

Authors:  Anna Aiello; Giulia Accardi; Giuseppina Candore; Giuseppe Carruba; Sergio Davinelli; Giuseppe Passarino; Giovanni Scapagnini; Sonya Vasto; Calogero Caruso
Journal:  Immun Ageing       Date:  2016-05-21       Impact factor: 6.400

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.